Cargando…

Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia

PURPOSE: To evaluate the impact of an optimal and reproducible cutoff value set according to a predefined lymphopenia scale as an early predictor of in-hospital mortality and other outcomes in patients hospitalized with pneumococcal pneumonia and positive urinary antigen at admission to the emergenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz, Luis A., Serrano, Leyre, Pérez, Silvia, Castro, Sonia, Urrutia, Amaia, Uranga, Ane, Artaraz, Amaia, Gómez, Ainhoa, España, Pedro P., Zalacain, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873546/ https://www.ncbi.nlm.nih.gov/pubmed/36694093 http://dx.doi.org/10.1007/s15010-023-01984-2

Ejemplares similares

Predicting 1-year mortality after hospitalization for community-acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2018)

Pneumococcal pneumonia: differences according to blood culture results
por: Capelastegui, Alberto, et al.
Publicado: (2014)

Diagnostic and therapeutic approach to occupational pneumonia
por: Yandiola, Pedro Pablo España, et al.
Publicado: (2022)

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study
por: Ruiz, Luis A., et al.
Publicado: (2017)

Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2021)

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
por: Serrano Fernández, Leyre, et al.
Publicado: (2022)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga MD, Ane, et al.
Publicado: (2020)

Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis
por: Pérez de Llano, Luis A., et al.
Publicado: (2022)

Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
por: Menéndez, Rosario, et al.
Publicado: (2022)

COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
por: Tabernero, Eva, et al.
Publicado: (2021)

High‐flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS‐CoV‐2 pneumonia out of ICU
por: Castro, Sonia, et al.
Publicado: (2023)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Predictors of mortality of COVID-19 in the general population and nursing homes
por: España, Pedro Pablo, et al.
Publicado: (2021)

Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia
por: Uranga, Ane, et al.
Publicado: (2022)

Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia
por: Bronte, O., et al.
Publicado: (2023)

Impact of Prior SARS-CoV-2 Infection and Vaccination on COVID-19 Infection Among Nursing Home Residents
por: España, Pedro P., et al.
Publicado: (2023)

Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents
por: España, Pedro P., et al.
Publicado: (2023)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
por: Menéndez, Rosario, et al.
Publicado: (2023)

Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
por: Endimiani, Andrea, et al.
Publicado: (2005)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
por: Principi, Nicola, et al.
Publicado: (2016)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Alteración funcional pulmonar en el seguimiento precoz de pacientes con neumonía por COVID-19
por: Tabernero Huguet, Eva, et al.
Publicado: (2021)

Pneumococcal Aetiology and Serotype Distribution in Paediatric Community-Acquired Pneumonia
por: De Schutter, Iris, et al.
Publicado: (2014)

Etiology of community-acquired pneumonia in a population-based study: Link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes
por: Capelastegui, Alberto, et al.
Publicado: (2012)

COPD classification models and mortality prediction capacity
por: Aramburu, Amaia, et al.
Publicado: (2019)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

1149. Contribution of S.pneumoniae Serotypes in Adults with Invasive Pneumococcal Disease (IPD) and Pneumococcal Community-acquired Pneumonia (pCAP)
por: Apodaca, Kevin, et al.
Publicado: (2023)

Methotrexate/steroids: Lymphopenia and Pneumocystis pneumonia: case report
Publicado: (2021)

Acute Pneumocystis jirovecii Pneumonia Due to Absolute Lymphopenia
por: Hilker, Eric, et al.
Publicado: (2022)

Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
por: Méndez, Raúl, et al.
Publicado: (2023)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
por: Shen, Ching-Fen, et al.
Publicado: (2020)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia
por: Montull, Beatriz, et al.
Publicado: (2016)

Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia
por: Kim, Byunghyun, et al.
Publicado: (2018)

Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU
por: Belkhouja, Khairallah, et al.
Publicado: (2011)

Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults
por: Isturiz, Raul, et al.
Publicado: (2015)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time
por: Esteban, Cristóbal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lnpttdiqi73qg9e8fkus49282r